C14orf143 Inhibitors
C14orf143 inhibitors encompass a range of compounds that exert their inhibitory effect through distinct yet interconnected biochemical pathways. These inhibitors act by targeting upstream signaling molecules, effectively reducing the functional activity of C14orf143. For instance, inhibition of kinase activity, which is essential for the phosphorylation and subsequent activation of many proteins, can lead to diminished C14orf143 activity. By blocking kinases that are potentially upstream of C14orf143, certain compounds ensure reduced phosphorylation, thus attenuating the protein's activity. Moreover, interference with pivotal cellular pathways like the PI3K/AKT/mTOR axis can indirectly influence the functional state of C14orf143. Compounds that inhibit PI3K or mTOR, both of which are integral to cell growth and survival signaling, can create a downstream effect that may involve the suppression of C14orf143's role in these processes.
Further, the MEK-ERK and p38 MAPK pathways are integral to cell proliferation and stress response, respectively. Inhibitors that curtail the activity of MEK, ERK, or p38 MAPK can lead to a decrease in C14orf143 activity if it is implicated in these pathways. Similarly, compounds that inhibit JNK attenuate the protein's involvement in apoptosis and proliferation pathways. Beyond these, modulators of cellular metabolism and gene expression, such as glycolysis inhibitors and histone deacetylase inhibitors, can also impinge upon C14orf143. They achieve this by either depriving it of the necessary energy for its activity or by altering the transcriptional landscape that includes C14orf143.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can inhibit a wide range of kinases which might be upstream of C14orf143 or involved in its activation. Inhibiting these kinases can lead to reduced phosphorylation and activity of C14orf143. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinase (PI3K) inhibitor. Given PI3K's role in multiple signaling pathways, its inhibition could decrease the activation of downstream targets including C14orf143. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which is part of the PI3K/AKT/mTOR pathway. As mTOR is a central regulator of cell growth and survival, its inhibition could downregulate proteins involved in these processes, including C14orf143. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor, which could lead to reduced ERK activation. Since ERK phosphorylates numerous substrates involved in cell proliferation, inhibition here could indirectly decrease the functional activity of C14orf143. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor. By inhibiting p38 MAPK, it could decrease the activation of proteins that are regulated by stress-activated pathways, including C14orf143. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, which can lead to a reduction in AKT activation. As AKT is a key regulator of cell survival and metabolism, its inhibition could influence the activity of C14orf143. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which can affect proteins involved in apoptosis and cell proliferation. Inhibition of JNK could therefore reduce the activity of proteins such as C14orf143 if it is involved in these cellular processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor. By altering chromatin structure and gene expression, it could indirectly lead to decreased expression or functional activity of C14orf143. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, which can lead to an accumulation of proteins for degradation and may affect protein turnover, impacting C14orf143 stability. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
A protein kinase C inhibitor. As PKC plays a role in various signaling pathways, its inhibition could impact the phosphorylation status and activity of proteins like C14orf143. | ||||||